Phase 1 Clinical Data Demonstrate Dose-Proportional PK, No Dose-Limiting Toxicities Through Four Dose Levels, and Concordance with Preclinical ...
The Fred Hutch Pharmacokinetics Laboratory (PK Lab) is a CAP/CLIA-certified clinical lab that provides therapeutic drug monitoring (TDM) services. We specialize in busulfan TDM, providing ...
MagnetisMM-9: An open-label, multicenter, non-randomized phase 1/2 study of elranatamab in patients with relapsed/refractory multiple myeloma. Background: Treatment of relapsed/refractory (R/R) ...
BUFFALO, N.Y. — When you pop a prescription pill into your mouth, you trust it to address the issue it was meant to fix. But what really happens? How is your body processing the drugs and what happens ...
In this study, an UPLC-MS/MS method with specificity and accuracy was established to simultaneously quantify aumolertinib, osimertinib, gefitinib and their major metabolites (left). By using this ...
A comprehensive overview of pharmacokinetics principles can be found in Chapter 5 of the widely used therapeutics textbook Pharmacotherapy: A Pathophysiologic Approach, 6th edition. [1] In addition, ...
Therapeutic superiority of a TCR-like antibody to an intracellular WT1 oncogene peptide compared with the tyrosine kinase inhibitor imatinib in a mouse model of Philadelphia chromosome positive (Ph+) ...
Irrespective of what therapeutic area or drug target a discovery program pursues, a common bottleneck that cannot be avoided is pharmacokinetics and safety. Thus, all drugs must enter the body, ...
The liver is the main site of drug metabolism, and we already know a lot about how the liver will transform drugs and have a good understanding of the enzymes involved. Yet when it comes to individual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results